SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-007258
Filing Date
2018-03-30
Accepted
2018-03-30 16:07:02
Documents
6
Period of Report
2018-03-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rare-8k_20180330.htm 8-K 34081
2 EX-1.1 rare-ex11_6.htm EX-1.1 23153
3 EX-5.1 rare-ex51_29.htm EX-5.1 9148
4 GRAPHIC g2018033017383467435050.jpg GRAPHIC 20102
5 GRAPHIC g2018033017383465535049.jpg GRAPHIC 4981
6 GRAPHIC g2018033017383467935050.jpg GRAPHIC 11976
  Complete submission text file 0001564590-18-007258.txt   119003
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 18726211
SIC: 2834 Pharmaceutical Preparations